L-arginine and Its Derivatives Correlate with Exercise Capacity in Patients with Advanced Heart Failure
Biomolecules · 2023
DOI: 10.3390/biom13030423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Anna Drohomirecka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Heart Failure and Transplantation, National Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland. Hauptthemen laut MEDLINE: Heart Failure, Heart Transplantation, Vascular Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Cardiology.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Methylated arginine metabolites interrupt nitric oxide synthesis, which can result in endothelium dysfunction and inadequate vasodilation. Since little is known about the dynamics of arginine derivatives in patients with heart failure (HF) during physical exercise, we aimed to determine this as well as its impact on the patient outcomes. Fifty-one patients with HF (left ventricle ejection fraction-LVEF ≤ 35%, mean 21.7 ± 5.4%) underwent the cardiopulmonary exercise test (CPET). Plasma concentrations of L-arginine, citrulline, ornithine, asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA) were measured before and directly after CPET. All patients were followed for a mean of 23.5 ± 12.6 months. The combined endpoint was: any death, urgent heart transplantation, or urgent LVAD implantation. L-arginine concentrations increased significantly after CPET (p = 0.02), when ADMA (p = 0.01) and SDMA (p = 0.0005) decreased. The parameters of better exercise capacity were positively correlated with post-CPET concentration of L-arginine and inversely with post-CPET changes in ADMA, SDMA, and baseline and post-CPET SDMA concentrations. Baseline and post-CPET SDMA concentrations increased the risk of endpoint occurrence (HR 1.02, 95% CI 1.009–1.03, p = 0.04 and HR 1.02, 95% CI 1.01–1.03, p = 0.02, respectively). In conclusion, in patients with HF, extensive exercise is accompanied by changes in arginine derivatives that can reflect endothelium function. These observations may contribute to the explanation of the pathophysiology of exercise intolerance in HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Heart Failure and Transplantation, National Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.
- Department of Medical Biology, National Institute of Cardiology, 04-628 Warsaw, Poland.
ORCID-Profile: Joanna Waś, Anna Lutyńska, Tomasz Zieliński
Förderung
- National Institute of Cardiology
Zitieren
APA
Drohomirecka, A., Waś, J., Wiligórska, N., Rywik, T. M., Komuda, K., Sokołowska, D., Lutyńska, A., & Zieliński, T. (2023). L-arginine and Its Derivatives Correlate with Exercise Capacity in Patients with Advanced Heart Failure. Biomolecules. https://doi.org/10.3390/biom13030423
Vancouver
Drohomirecka A, Waś J, Wiligórska N, Rywik TM, Komuda K, Sokołowska D, et al. L-arginine and Its Derivatives Correlate with Exercise Capacity in Patients with Advanced Heart Failure. Biomolecules. 2023. doi:10.3390/biom13030423
BibTeX
@article{Drohomirecka2023,
author = {Drohomirecka, Anna and Waś, Joanna and Wiligórska, Natalia and Rywik, Tomasz M and Komuda, Krzysztof and Sokołowska, Dorota and Lutyńska, Anna and Zieliński, Tomasz},
title = {L-arginine and Its Derivatives Correlate with Exercise Capacity in Patients with Advanced Heart Failure},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13030423}
}
EUVIMED